In the original publication [1], there was a mistake in Table S5 (adults), which was a duplicate of Table S5 (children). The corrected Table S5 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Table S5.
Meta-analysis of serotype-specific proportion * of IPD isolates from children and adults.
| Children | Serotype | N (Studies) | Proportion (95% CI) |
|---|---|---|---|
| PCV13 NIP, initial period (<3 years) | |||
| All PCV13 | 26 | 50.3 (41.3–59.3) | |
| PCV20nonPCV13 | |||
| 8 | 22 | 2.1 (1.3–3.3) | |
| 10A | 24 | 3.5 (2.8–4.4) | |
| 11A | 20 | 1.9 (1.3–2.9) | |
| 12F | 24 | 4.4 (2.6–7.6) | |
| 15B/C | 31 | 7.2 (5.6–9.1) | |
| 22F | 25 | 3.6 (2.5–5.3) | |
| 33F | 23 | 3.2 (2.3–4.6) | |
| PCV13 NIP, later period (≥3 years) | |||
| All PCV13 | 17 | 44.5 (30.6–59.3) | |
| PCV20nonPCV13 | |||
| 8 | 19 | 3.8 (2.5–5.8) | |
| 10A | 18 | 5.9 (4.5–7.7) | |
| 11A | 15 | 1.9 (1.6–2.3) | |
| 12F | 20 | 4.9 (3.2–7.4) | |
| 15B/C | 18 | 6.2 (4.4–8.7) | |
| 22F | 20 | 4.2 (2.7–6.3) | |
| 33F | 18 | 4.4 (3.0–6.4) | |
| Adults | Serotype | N (Studies) | Proportion (95% CI) |
| PCV13 NIP, initial period (<3 years) | |||
| All PCV13 | 13 | 49.5 (45.0–57.0) | |
| PCV20nonPCV13 | |||
| 8 | 10 | 4.1 (1.6–10.4) | |
| 10A | 8 | 1.8 (1.0–3.5) | |
| 11A | 10 | 3.7 (2.4–5.6) | |
| 12F | 7 | 2.4 (1.5–4.0) | |
| 15B/C | 11 | 2.5 (1.7–3.6) | |
| 22F | 13 | 7.7 (5.9–9.9) | |
| 33F | 7 | 1.8 (1.2–2.7) | |
| PCV13 NIP, later period (≥3 years) | |||
| All PCV13 | 9 | 27.3 (19.6–36.7) | |
| PCV20nonPCV13 | |||
| 8 | 13 | 10.2 (7.6–13.4) | |
| 10A | 13 | 2.4 (1.9–3.0) | |
| 11A | 13 | 2.7 (2.4–3.1) | |
| 12F | 13 | 6.2 (4.7–8.1) | |
| 15B/C | 11 | 1.5 (1.2–2.0) | |
| 22F | 13 | 6.7 (5.7–7.8) | |
| 33F | 12 | 2.5 (1.8–3.4) | |
* Calculated with a binomial random-effects meta-analytic model for each serotype-specific proportion independently. Consequently, the sum of all PCV20nonPCV13 serotypes may exceed 100%.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Méroc E., Fletcher M.A., Hanquet G., Slack M.P.E., Baay M., Hayford K., Gessner B.D., Grant L.R. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. Microorganisms. 2023;11:1816. doi: 10.3390/microorganisms11071816. [DOI] [PMC free article] [PubMed] [Google Scholar]